IRIS - Res&Arch Institutional Research Information System - Research & Archive

PAOLINI PAOLETTI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.161
AS - Asia 1.041
EU - Europa 587
SA - Sud America 140
AF - Africa 26
OC - Oceania 3
Totale 2.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.136
SG - Singapore 511
CN - Cina 162
HK - Hong Kong 127
IT - Italia 110
BR - Brasile 107
IE - Irlanda 107
RU - Federazione Russa 90
VN - Vietnam 74
DE - Germania 70
FR - Francia 49
FI - Finlandia 40
KR - Corea 40
IN - India 36
GB - Regno Unito 26
RO - Romania 21
CA - Canada 18
NL - Olanda 14
BD - Bangladesh 13
IQ - Iraq 13
AR - Argentina 12
SE - Svezia 11
AT - Austria 10
JP - Giappone 10
TR - Turchia 8
VE - Venezuela 8
ZA - Sudafrica 8
CO - Colombia 6
ES - Italia 6
ID - Indonesia 6
PL - Polonia 6
UZ - Uzbekistan 6
PK - Pakistan 5
SA - Arabia Saudita 5
TN - Tunisia 5
NP - Nepal 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
CH - Svizzera 3
LT - Lituania 3
MD - Moldavia 3
MX - Messico 3
MY - Malesia 3
OM - Oman 3
AU - Australia 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
IS - Islanda 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
MA - Marocco 2
PH - Filippine 2
PY - Paraguay 2
SN - Senegal 2
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
MM - Myanmar 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PT - Portogallo 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 2.958
Salva come PNG Salva come JPEG
Città #
Singapore 386
Chandler 167
San Jose 142
Hong Kong 126
Dublin 107
Ashburn 91
Boardman 59
Santa Clara 41
Seoul 40
Perugia 37
San Mateo 35
Munich 34
Lauterbourg 33
Los Angeles 33
Beijing 31
Moscow 31
Helsinki 21
Ho Chi Minh City 19
Timisoara 19
Hanoi 18
Lawrence 18
Medford 18
Princeton 18
São Paulo 18
New York 17
Piscataway 17
Turku 17
Wilmington 17
The Dalles 15
Altamura 14
Chennai 13
Falls Church 13
Andover 12
Des Moines 12
Brooklyn 11
Nuremberg 10
Redwood City 10
Tokyo 10
Montreal 9
Orem 9
Dallas 8
Houston 8
Milan 8
Stockholm 8
Amsterdam 7
Frankfurt am Main 7
London 7
Rome 7
Boston 6
Poplar 6
Tashkent 6
West Jordan 6
Baghdad 5
Council Bluffs 5
Da Nang 5
Denver 5
Dong Ket 5
Fairfield 5
Hefei 5
Redmond 5
Atlanta 4
Belo Horizonte 4
Chicago 4
Columbus 4
Curitiba 4
Saint Petersburg 4
Verona 4
Warsaw 4
City of London 3
Cosenza 3
El Paso 3
Guangzhou 3
Johannesburg 3
Medellín 3
Mumbai 3
Muscat 3
New Delhi 3
Phoenix 3
Porto Alegre 3
Rio de Janeiro 3
San Paolo di Civitate 3
Tirana 3
Tunis 3
Vienna 3
Al Hillah 2
Amman 2
Aryanah 2
Brixen 2
Brussels 2
Cachoeirinha 2
Cali 2
Campinas 2
Cape Town 2
Caracas 2
Carney 2
Casablanca 2
Chisinau 2
Dakar 2
Delhi 2
Dubai 2
Totale 1.984
Salva come PNG Salva come JPEG
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 125
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 120
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 108
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 107
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 106
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 101
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 101
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 100
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 97
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 96
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 93
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 93
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 84
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 82
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 80
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 79
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 79
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 78
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 77
Levodopa treatment in Parkinson's disease: earlier or later? 77
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 76
Blood biomarkers may distinguish among dementia disorders 76
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 76
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 67
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 66
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 66
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 66
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 64
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 58
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 57
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 57
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 56
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 56
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 54
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 54
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 53
Research advancement in fluid biomarkers for Parkinson's disease 45
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 31
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 16
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 15
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 13
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 13
Totale 3.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 8 2 6
2021/2022134 0 23 0 0 5 8 4 34 10 11 20 19
2022/2023467 19 104 7 35 41 51 1 27 154 5 14 9
2023/2024253 16 25 8 4 4 2 42 6 46 12 45 43
2024/2025625 11 51 38 36 60 44 21 43 118 48 101 54
2025/20261.427 98 104 60 191 212 128 259 83 163 129 0 0
Totale 3.018